Skip to main content

Table 5 Comparison between patients’ number, clinical stages, grades, and tumor type, in our studies and other series

From: Upper Egypt experience in bladder preservation using concurrent chemoradiotherapy

  Arias, et al., 2000 [6] Caffo et al., 2003 [8] Caffo et al., 2003 [8] Sakr et al., 2003 [9] Soliman et al., 2004 [10] Group A Group B
Patients number 50 415 16 30 25 30 30
Tumor type TCC TCC TCC Mixed (TCC & SCC) TCC TCC Mixed
T1 _____ 21% _____ _____ ______ _____ ______
T2 68% 51% 88.9% 53.4% 48% 36.6% 90%
T3 32% 7% _____ 46.6% 52% 59.9% 10%
T4a _____ ____ 11.1% ______ _______ 3.3% _______
GI 10% ______ unknown ______ _______ _____ 36.7%
GII 40% 47.5% unknown 76.6% 60% 60% 33.3%
GIII 50% 52.5% unknown 23.4% 40% 40% 30%